These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24389478)

  • 1. Discovery of a novel nicotinamide phosphoribosyl transferase (NAMPT) inhibitor via in silico screening.
    Takeuchi M; Niimi T; Masumoto M; Orita M; Yokota H; Yamamoto T
    Biol Pharm Bull; 2014; 37(1):31-6. PubMed ID: 24389478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.
    Zhang RY; Qin Y; Lv XQ; Wang P; Xu TY; Zhang L; Miao CY
    Anal Biochem; 2011 May; 412(1):18-25. PubMed ID: 21211508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening.
    Ozgencil F; Eren G; Ozkan Y; Guntekin-Ergun S; Cetin-Atalay R
    Bioorg Med Chem; 2020 Jan; 28(1):115217. PubMed ID: 31818629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induced by NAD depletion is inhibited by KN-93 in a CaMKII-independent manner.
    Takeuchi M; Yamamoto T
    Exp Cell Res; 2015 Jul; 335(1):62-7. PubMed ID: 26024774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy.
    Ozgencil F; Gunindi HB; Eren G
    Bioorg Chem; 2024 Aug; 149():107509. PubMed ID: 38824699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD
    Guo J; Lam LT; Longenecker KL; Bui MH; Idler KB; Glaser KB; Wilsbacher JL; Tse C; Pappano WN; Huang TH
    Biochem Biophys Res Commun; 2017 Sep; 491(3):681-686. PubMed ID: 28756225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase.
    Xu TY; Zhang SL; Dong GQ; Liu XZ; Wang X; Lv XQ; Qian QJ; Zhang RY; Sheng CQ; Miao CY
    Sci Rep; 2015 Jun; 5():10043. PubMed ID: 26040985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism.
    Burgos ES
    Curr Med Chem; 2011; 18(13):1947-61. PubMed ID: 21517777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives.
    Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X
    Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.
    Montecucco F; Cea M; Bauer I; Soncini D; Caffa I; Lasigliè D; Nahimana A; Uccelli A; Bruzzone S; Nencioni A
    Curr Drug Targets; 2013 Jun; 14(6):637-43. PubMed ID: 23531116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.
    Chen H; Wang S; Zhang H; Nice EC; Huang C
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):827-38. PubMed ID: 27186719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
    Dragovich PS; Zhao G; Baumeister T; Bravo B; Giannetti AM; Ho YC; Hua R; Li G; Liang X; Ma X; O'Brien T; Oh A; Skelton NJ; Wang C; Wang W; Wang Y; Xiao Y; Yuen PW; Zak M; Zhao Q; Zheng X
    Bioorg Med Chem Lett; 2014 Feb; 24(3):954-62. PubMed ID: 24433859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase.
    Chen W; Dong G; He S; Xu T; Wang X; Liu N; Zhang W; Miao C; Sheng C
    Bioorg Med Chem Lett; 2016 Feb; 26(3):765-768. PubMed ID: 26755394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of NAMPT in adult T-cell leukemia/lymphoma and anti-tumor activity of a NAMPT inhibitor.
    Kozako T; Aikawa A; Ohsugi T; Uchida YI; Kato N; Sato K; Ishitsuka K; Yoshimitsu M; Honda SI
    Eur J Pharmacol; 2019 Dec; 865():172738. PubMed ID: 31614144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into Xanthomonas campestris pv. campestris NAD
    Xu G; Ma J; Fang Q; Peng Q; Jiao X; Hu W; Zhao Q; Kong Y; Liu F; Shi X; Tang DJ; Tang JL; Ming Z
    Commun Biol; 2024 Mar; 7(1):255. PubMed ID: 38429435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents.
    Li Y; Kong X; Chu X; Fu H; Feng X; Zhao C; Deng Y; Ge J
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
    Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
    J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NAMPT for Therapeutic Intervention in Cancer and Inflammation: Structure-Based Drug Design and Biological Screening.
    Pulla VK; Sriram DS; Soni V; Viswanadha S; Sriram D; Yogeeswari P
    Chem Biol Drug Des; 2015 Oct; 86(4):881-94. PubMed ID: 25850461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of structural determinants of nicotinamide phosphoribosyl transferase (NAMPT) activity and substrate selectivity.
    Houry D; Raasakka A; Ferrario E; Niere M; Bifulco E; Kursula P; Ziegler M
    J Struct Biol; 2023 Sep; 215(3):108004. PubMed ID: 37495196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT.
    Wang X; Xu TY; Liu XZ; Zhang SL; Wang P; Li ZY; Guan YF; Wang SN; Dong GQ; Zhuo S; Le YY; Sheng CQ; Miao CY
    Sci Rep; 2015 Jul; 5():12657. PubMed ID: 26227784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.